Delivery Order SPE2DB20D3303-SPE2DB24FZ4V1

Award Date 4/16/24
Potential Completion Date 5/7/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,328.52 and an ultimate completion date of July 10, 2024. It is a firm-fixed-price Delivery Order contract, without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 200 unit vials of BOTOX to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award has a ceiling value of $13,971.12 and is structured as a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $10,257.48 and has a completion date of February 26, 2025. The contract is for the supply of BOTOX 200 unit vials, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a total ceiling value of $13,971.12 and an ultimate completion date of August 2, 2024. The contract is a delivery order, with a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BOTOX 100 unit vials. The $4,306.80 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 20, 2025. The contract is not set aside for any particular business type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $8,731.95 for the supply of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has a Firm Fixed Price pricing type and a completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 200-unit vials of Botox. The total ceiling value of the contract is $6,985.56, and it is a Firm Fixed Price type contract. The ultimate completion date is May 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 200-unit vials of BOTOX. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The $17,095.80 firm fixed-price delivery order is for the supply of 4567005593 BOTOX 200 UNIT VIALS. The award has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
Amerisourcebergen Drug Corp, a for-profit global pharmaceutical company, has been awarded a Firm Fixed Price Delivery Order contract worth $3,492.78 from the Defense Logistics Agency (DLA) to provide 200 unit vials of BOTOX. The contract has a completion date of March 15, 2024 and was awarded on February 23, 2024. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ4V1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 200-unit vials of the pharmaceutical product BOTOX. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,328.52 and an ultimate completion date of May 7, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and does not have a set-aside designation.

Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 7/16/24, 12:45 PM